Aurinia Pharmaceuticals (AUPH) Other Operating Expenses (2019 - 2026)

Aurinia Pharmaceuticals (AUPH) has 8 years of Other Operating Expenses data on file, last reported at -$279000.0 in Q1 2026.

• Quarterly Other Operating Expenses rose 93.7% year-over-year to -$279000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.4 million (down 27.88% YoY) and the FY2025 annual result came in at -$9.5 million, down 319.23% from the prior year.
• Other Operating Expenses declined to -$279000.0 in Q1 2026, from $5.1 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $5.1 million in Q4 2025 to a low of -$9.2 million in Q2 2025.
• A 5-year average of -$724588.2 and a median of -$279000.0 in 2026 frame the typical range for Other Operating Expenses.
• Annual changes were most pronounced in 2024 — Other Operating Expenses surged 1522.41% — and 2025, when it tumbled 3288.28%.
• Tracing AUPH's Other Operating Expenses over 5 years: stood at $2.2 million in 2022, then slumped by 518.16% to -$9.1 million in 2023, then surged by 149.66% to $4.5 million in 2024, then grew by 12.61% to $5.1 million in 2025, then plunged by 105.5% to -$279000.0 in 2026.
• The last three Other Operating Expenses figures came in at -$279000.0 (Q1 2026), $5.1 million (Q4 2025), and -$929000.0 (Q3 2025), per Business Quant data.